-+ 0.00%
-+ 0.00%
-+ 0.00%

Thermo Fisher Scientific Agrees To Sell Microbiology Business To Astorg For Consideration Of ~$1.075B, Consisting Of Cash And $50M Seller Note

Benzinga·04/27/2026 12:09:10
Listen to the news

Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that it has signed a definitive agreement to sell its microbiology business to Astorg, a leading pan-European private equity firm, forconsideration of approximately $1.075 billion, consisting of cash and a $50 million seller note.

The microbiology business provides antimicrobial susceptibility testing and culture media solutions for clinical, pharmaceutical and food safety testing. The business generated $645 million in revenue in 2025 and is part of Thermo Fisher's Specialty Diagnostics segment.